Haploid Technologies has developed a groundbreaking new technology that enables precise assignment of phase across multiple ...

The ongoing GARDian3 study is designed to assess whether a single subretinal administration of OCU410ST can slow structural ...

Brian Tait calls for public support to fund exciting groundbreaking technology for assigning phase to multiple mutations ...

CHARLESTOWN, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for ...

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and ...

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

- Strong Capital Position: Cash, cash equivalents and available-for-sale securities of $187.9 million at December 31, 2025; in March 2026, the Company completed a $240 million private placement; the ...

ND4 variant (m.11232T>C) to severe neurologic injury after sevoflurane in patients with Venezuelan maternal ancestry, prompting international alerts.

Researchers at the University of Minnesota Medical School have developed a new method called PARTAGE that provides a clearer ...

Air pollution activates macrophage-derived artemin, sensitizing TRPA1 nociceptors to drive neutrophilic asthma, revealing new therapeutic targets for refractory airway inflammation.

President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a university in Virginia and a synagogue ...